e-learning
resources
Vienna 2012
Monday, 03.09.2012
Asthma: mechanisms of airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A low total sputum cell count is a marker for asthma remission during adolescence
K. Bawakid, Z. Al-Shammari, L. Lau, W. Karmaus, S. Ewart, R. Kurukulaaratchy, G. Roberts, A. Raza, H. Arshad (Southampton, United Kingdom; East Lansing, United States Of America)
Source:
Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Session:
Asthma: mechanisms of airway inflammation
Session type:
Thematic Poster Session
Number:
2371
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Bawakid, Z. Al-Shammari, L. Lau, W. Karmaus, S. Ewart, R. Kurukulaaratchy, G. Roberts, A. Raza, H. Arshad (Southampton, United Kingdom; East Lansing, United States Of America). A low total sputum cell count is a marker for asthma remission during adolescence. Eur Respir J 2012; 40: Suppl. 56, 2371
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Source: Eur Respir J 2006; 27: 483-494
Year: 2006
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation?
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020
Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 114s
Year: 2002
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
Are symptoms of chronic bronchitis and sputum inflammatory cell counts related to the duration of smoking cessation in COPD?
Source: Eur Respir J 2004; 24: Suppl. 48, 45s
Year: 2004
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Interleukine-13 in induced sputum in clinical remission asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 175s
Year: 2003
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children
Source: Annual Congress 2011 - Flexible bronchoscopy in the diagnosis of paediatric lung diseases
Year: 2011
Sputum eosinophil percentages during a moderate exacerbation of asthma and during a natural cold
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept